A European Phase III, Multicentre, Double-blind, Randomised, Placebo-controlled Monotherapy Study of Milnacipran for the Treatment of Fibromyalgia Syndrome
Latest Information Update: 23 Nov 2020
At a glance
- Drugs Milnacipran (Primary)
- Indications Fibromyalgia
- Focus Registrational; Therapeutic Use
- Sponsors Pierre Fabre
- 24 Oct 2020 Results of two large analgesic clinical trials (NCT00098124 and NCT00436033) for the treatment of fibromyalgia to evaluate the utility of different pain indices for detecting intervention effects, published in the Journal of Pain.
- 02 Jul 2009 Results presented at 9th World Congress of Biological Psychiatry.
- 20 May 2009 Results have been presented at the 162nd Annual Meeting of the American Psychiatric Association.